BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28558662)

  • 21. Diagnostic accuracy and turnaround time of the Xpert MTB/RIF assay in routine clinical practice.
    Kwak N; Choi SM; Lee J; Park YS; Lee CH; Lee SM; Yoo CG; Kim YW; Han SK; Yim JJ
    PLoS One; 2013; 8(10):e77456. PubMed ID: 24204834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses.
    Kendall EA; Kamoga C; Kitonsa PJ; Nalutaaya A; Salvatore PP; Robsky K; Nakasolya O; Mukiibi J; Isooba D; Cattamanchi A; Kato-Maeda M; Katamba A; Dowdy DW
    PLoS One; 2019; 14(7):e0220251. PubMed ID: 31339935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of introduction of Xpert MTB/RIF test on tuberculosis (TB) diagnosis in a city with high TB incidence in Brazil.
    Pereira GR; Barbosa MS; Dias NJD; Almeida CPB; Silva DR
    PLoS One; 2018; 13(3):e0193988. PubMed ID: 29518135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study.
    Zürcher K; Ballif M; Kiertiburanakul S; Chenal H; Yotebieng M; Grinsztejn B; Michael D; Sterling TR; Ngonyani KM; Mandalakas AM; Egger M; Pettit AC; Fenner L;
    J Int AIDS Soc; 2019 Sep; 22(9):e25392. PubMed ID: 31507083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission by systematic testing of urine samples using Xpert MTB/RIF: a prospective cohort in South Africa.
    Lawn SD; Kerkhoff AD; Burton R; Schutz C; van Wyk G; Vogt M; Pahlana P; Nicol MP; Meintjes G
    BMC Med; 2015 Aug; 13():192. PubMed ID: 26275908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic challenges and Gene-Xpert utility in detecting Mycobacterium tuberculosis among suspected cases of Pulmonary tuberculosis.
    Kabir S; Parash MTH; Emran NA; Hossain ABMT; Shimmi SC
    PLoS One; 2021; 16(5):e0251858. PubMed ID: 34015016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial.
    Cox HS; Mbhele S; Mohess N; Whitelaw A; Muller O; Zemanay W; Little F; Azevedo V; Simpson J; Boehme CC; Nicol MP
    PLoS Med; 2014 Nov; 11(11):e1001760. PubMed ID: 25423041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique.
    Floridia M; Ciccacci F; Andreotti M; Hassane A; Sidumo Z; Magid NA; Sotomane H; David M; Mutemba E; Cebola J; Mugunhe RJ; Riccardi F; Marazzi MC; Giuliano M; Palombi L; Mancinelli S
    Clin Infect Dis; 2017 Nov; 65(11):1878-1883. PubMed ID: 29020319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in stool samples of adults with pulmonary tuberculosis.
    Rahman SMM; Maliha UT; Ahmed S; Kabir S; Khatun R; Shah JA; Banu S
    PLoS One; 2018; 13(9):e0203063. PubMed ID: 30212505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality in the first six months among HIV-positive and HIV-negative patients empirically treated for tuberculosis.
    Huerga H; Ferlazzo G; Wanjala S; Bastard M; Bevilacqua P; Ardizzoni E; Sitienei J; Bonnet M
    BMC Infect Dis; 2019 Feb; 19(1):132. PubMed ID: 30744603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A descriptive study of smear negative pulmonary tuberculosis in a high HIV burden patient's population in North Central Nigeria.
    Tiamiyu AB; Iliyasu G; Dayyab FM; Habib ZG; Tambuwal SH; Animashaun AO; Galadanci H; Bwala SA; Lawson L; Habib AG
    PLoS One; 2020; 15(9):e0238007. PubMed ID: 32870914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
    Kawasaki M; Echiverri C; Raymond L; Cadena E; Reside E; Gler MT; Oda T; Ito R; Higashiyama R; Katsuragi K; Liu Y
    PLoS Med; 2019 Apr; 16(4):e1002780. PubMed ID: 30978194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.
    van Kampen SC; Tursynbayeva A; Koptleuova A; Murzakhmetova Z; Bigalieva L; Aubakirova M; Pak S; van den Hof S
    PLoS One; 2015; 10(7):e0132514. PubMed ID: 26181578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.
    Rachow A; Zumla A; Heinrich N; Rojas-Ponce G; Mtafya B; Reither K; Ntinginya EN; O'Grady J; Huggett J; Dheda K; Boehme C; Perkins M; Saathoff E; Hoelscher M
    PLoS One; 2011; 6(6):e20458. PubMed ID: 21738575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study.
    Zar HJ; Workman L; Isaacs W; Dheda K; Zemanay W; Nicol MP
    Lancet Glob Health; 2013 Aug; 1(2):e97-e104. PubMed ID: 25104164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a Single Xpert MTB/RIF Assay to Determine the Duration of Airborne Isolation in Hospitalized Patients With Suspected Pulmonary Tuberculosis.
    Poonawala H; Leekha S; Medina-Moreno S; Filippell M; Johnson JK; Redfield RR; Saharia KK
    Infect Control Hosp Epidemiol; 2018 May; 39(5):590-595. PubMed ID: 29582718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.
    Friedrich SO; Rachow A; Saathoff E; Singh K; Mangu CD; Dawson R; Phillips PP; Venter A; Bateson A; Boehme CC; Heinrich N; Hunt RD; Boeree MJ; Zumla A; McHugh TD; Gillespie SH; Diacon AH; Hoelscher M;
    Lancet Respir Med; 2013 Aug; 1(6):462-70. PubMed ID: 24429244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the Xpert MTB/RIF assay for the diagnosis of smear-negative pulmonary and extrapulmonary tuberculosis in Madagascar.
    Rakotoarivelo R; Ambrosioni J; Rasolofo V; Raberahona M; Rakotosamimanana N; Andrianasolo R; Ramanampamonjy R; Tiaray M; Razafimahefa J; Rakotoson J; Randria M; Bonnet F; Calmy A;
    Int J Infect Dis; 2018 Apr; 69():20-25. PubMed ID: 29408360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.
    Lawn SD; Kerkhoff AD; Vogt M; Wood R
    Lancet Infect Dis; 2012 Mar; 12(3):201-9. PubMed ID: 22015305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Xpert MTB/RIF Ultra Assay Using Stool: an Effective Solution for Bacilli Identification from Adult Pulmonary Tuberculosis Suspects without Expectorated Sputum.
    Yu X; Wang F; Ren R; Dong L; Xue Y; Zhao L; Jia J; Huang H
    Microbiol Spectr; 2023 Aug; 11(4):e0126523. PubMed ID: 37378554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.